Publications by authors named "Thomas Tassin"

Claim this Profile
O
Optimizing Wilms tumor 1 thresholds for measurable residual disease monitoring in acute myeloid leukemia: Improved sensitivity and concordance with nucleophosmin 1 in a single-center validation study.
Sabrina Barriere, Céline Bourgne, Thomas Tassin, Anais Establie, Ines Ramos

Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplex digital PCR enables sensitive detection of resistance to BTK inhibitors.
Manon Garcia, Carolyne Croizier, Grégory Lazarian, Anne Quinquenel, Thomas Tassin

Ann Hematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of molecular characterization to the diagnosis of MPN in patients with low JAK2 variant allelic fraction in a real-world cohort.
Benjamin Lebecque, Carolyne Croizier, Thomas Tassin, Esteban Louis, Nathalie Tribalat

Ann Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Use of HemoCue® or portable hemoglobinometer: results of the national surveys carried out by the SFBC POCT working group].
Thomas Tassin, Ludovic Glady, Valérie Moal, Nathalie Oueidat, Isabelle Martinel

Ann Biol Clin (Paris)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytopenias revealing a case of carcinocythemia with bone marrow metastasis.
Thomas Tassin, Benjamin Lebecque

Am J Hematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Near-early T-cell precursor acute lymphoblastic leukemia following a diagnosis of essential thrombocythemia.
Benjamin Lebecque, Thomas Tassin

EJHaem· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia.
Benjamin Lebecque, Celine Bourgne, Chinmay Munje, Juliette Berger, Thomas Tassin

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mast cell density and its clinical relevance in Waldenström's macroglobulinemia.
Richard Lemal, Stéphanie Poulain, Albane Ledoux-Pilon, Lauren Veronese, Andrei Tchirkov, Thomas Tassin

EJHaem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double L611S/V617F JAK2 mutation in a child with erythrocytosis.
Benjamin Lebecque, Victoria Grèze, Thomas Tassin, Gabrielle Mareynat, Louis-Thomas Dannus

Pediatr Blood Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34 and immature CD34 cells.
Marc G Berger, Benjamin Lebecque, Thomas Tassin, Louis-Thomas Dannus, Juliette Berger

Sci Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a rapid centrifugation step (4500 g for 2 min) in coagulation assays to monitor direct oral anticoagulants.
Justine Brulé, Solène Revy, Charlotte Faure, Romain Eschalier, Grégoire Massoullié, Thomas Tassin

Clin Chem Lab Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis